Blissco Signs Agreement to Supply New Brunswick with Premium Cannabis
VANCOUVER, British Columbia, March 26, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia, a licensed processor and producer of premium dried cannabis and cannabis oil, and a licensed distributor of dried cannabis products. The Company is pleased to announce that it has signed a one-year renewable supply agreement with Cannabis NB.
Cannabis NB is a subsidiary of Alcohol New Brunswick Liquor (ANBL) and the only legal retailer of recreational cannabis for the province of New Brunswick. The corporation sells directly to consumers online and operates 20 stand-alone recreational cannabis retail stores.
We’re excited to make Blissco our 7th official supply partner and we look forward to successfully launching their brand in our retail network
said Lara Wood, General Manager of Cannabis NB.
Blissco agrees to supply the province with up to 18 whole flower and pre-roll products from 6 strains of their Reserve and Blissco Collection including:
- AC/DC from the Blissco ‘CONNECT Collection’; a CBD dominant, evenly balanced Sativa and Indica hybrid with a Pinene and Caryophyllene terpene profile
- Green Cush from the Blissco ‘GO Collection’; a THC dominant, Sativa hybrid with a well-balanced Pinene and Caryophyllene terpene profile
- Cold Creek Kush from the Blissco ‘EASE Collection’; a THC dominant, Indica hybrid with a Pinene dominant terpene profile
- Blissco Reserve White Widow from the Blissco 'CREATE Collection'; a THC dominant, Indica hybrid with a Mycrene, Limonene, Guaiol and Caryophyllene terpene profile
- Blissco Reserve Cheese Quake from the Blissco 'CREATE Collection'; a THC dominant, Sativa hybrid with a Caryophyllene, Limonene and Humulene terpene profile
- Blissco Reserve CBD Shark Shock from the Blissco ‘CONNECT Collection’; a CBD dominant, Indica hybrid with Caryophyllene and Limonene terpene profile
Becoming one of Cannabis NB’s early supply partners is very exciting for Blissco
said Damian Kettlewell, Blissco CEO.
We are pleased to see that the demand for Blissco’s premium whole flower cannabis is growing and that retailers from across Canada are seeking our products
Blissco now holds supply agreements for British Columbia, Alberta, Saskatchewan, and New Brunswick, and are also on track to supply international markets, starting with Germany.
Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a Canadian wellness cannabis brand based in British Columbia and a multi-licensed processor, cultivator, and distributor of premium cannabis.
Blissco owns and operates an 18,000 square foot, state-of-the-art facility located in Metro Vancouver, British Columbia with extraction, cultivation and processing rooms. Blissco is supplying premium cannabis and small-batch Reserve whole flower and dried flower pre-rolls to the Canadian market with supply agreements in British Columbia, Alberta, Saskatchewan, and New Brunswick. In support of Blissco’s global distribution strategy, the company has initiated its EU GMP certification process and has completed its first inspection by German authorities.
With a licence to process cannabis oil acquired in August 2018, Blissco’s extraction lab is also in operation preparing a line of full spectrum oils for distribution in 2019.
Learn more at blissco.com
For your convenience, download or view the Blissco Investor Presentation, February 2019.
On Behalf of the Board of Directors
BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair
For further information please contact:
1 604 484-9119
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.